Lupin Pharma launches ‘Covihalt’ for treatment of mild to moderate COVID-19 symptoms

Well known Pharma manufacturer Lupin Ltd. on Wednesday announced the launch of generic ‘favipiravir’ under the name ‘Covihalt’ for treatment of those to develop mild to moderate symptoms of... Read more »